Diabetic neuropathy: scope of the syndrome.
Greene
D A
DA
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0354, USA.
Stevens
M J
MJ
Feldman
E L
EL
D000449:Aldehyde Reductase / Q000627:therapeutic use; D000818:Animals; D002908:Chronic Disease; D018849:Controlled Clinical Trials as Topic; D017719:Diabetic Foot; D003929:Diabetic Neuropathies / Q000145:classification / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D018450:Disease Progression; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D009431:Neural Conduction / Q000187:drug effects; D015995:Prevalence; D011799:Quinazolines / Q000627:therapeutic use; D013577:Syndrome
D004791:Enzyme Inhibitors; D011799:Quinazolines; C064920:FR 74366; D000449:Aldehyde Reductase